stockrow
Friday 6 November 2026
Export SERA’s income statement to Excel — free account
Sera Prognostics, Inc.
SERA Healthcare Medical Devices
Sera Prognostics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $81,000.00, up 5.19% from fiscal 2024.
- Revenue
- +162.5%
- EPS
- +0.88%
- Free cash flow
- −12.8%
Quarter to September 2026, against a year earlier
2.16
0.08
+3.85%
Follow SERA
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | — | 3 |
+8 more TTM periods Free account |
| (49.73%) | (45.03%) | (39.58%) | (51.83%) | ||
| (35.59%) | (33.47%) | (30.36%) | (36.59%) | ||
ROIC |
(278.58%) | (180.22%) | (113.18%) | (63.01%) | |
Return on Tangible Assets |
(142.94%) | (131.88%) | (117.29%) | (180.07%) | |
Average Days of Receivables |
64.64 | 52.14 | 70.44 | 54.07 | |
Free Cash Flow per Share |
(0.58) | (0.57) | (0.55) | (0.55) | |
Free Cash Flow |
(29.37) | (28.53) | (27.57) | (26.35) | |
Capital Expenditures |
(0.87) | (0.85) | (0.73) | (0.73) | |
| Other line items | |||||
Cash ROIC |
(30.43%) | (26.96%) | (23.97%) | (22.99%) | |
Accounts Receivable Turnover |
6.19 | 5.19 | 3.17 | 3.52 | |
Accounts Payable Turnover |
0.18 | 0.16 | 0.17 | 0.12 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
2,178.77 | 2,482.00 | 1,686.48 | 1,918.48 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
12,980.21% | 18,604.29% | 22,573.68% | 16,260.49% | |
Selling, General and Administrative Expense of Revenue |
25,671.88% | 34,528.57% | 41,470.18% | 28,703.70% | |
Share Based Compensation of Revenue |
4,122.92% | 5,615.71% | 7,810.53% | 6,308.64% | |
Interest Coverage |
(5,315.00) | (5,328.29) | (5,230.57) | (4,056.00) | |
Operating CF/Net income |
0.85 | 0.83 | 0.84 | 0.80 | |
Depreciation/Fixed assets |
0.48 | 0.61 | 0.84 | 0.82 | |
Capex/Depreciation |
(1.06) | (0.98) | (0.80) | (0.77) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.56) | (0.55) | (0.53) | (0.54) | |
Capex per Share |
(0.02) | (0.02) | (0.01) | (0.02) | |
Capex to Sales |
9.08 | 12.14 | 12.82 | 8.96 |
Columns are period end dates · fundamentals updated 6 Nov 2026